Kevin Nowicki, MD
Neuromusculoskeletal Medicine, Sports Medicine · Clermont, FLNPI 1154313021
Payments from drug & device makers
What this record shows
This record is dominated by education: $5,270 of the $6,973 with a category attached, or 75.6%. 17 manufacturers reported payments, led by Reel Surgical, Inc. at 55.0% of the total. Reporting peaked in 2021 at $2,855 and has fallen 94.4% since, to $159 in 2025.
Across 50 payments — averaging $139.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Reel Surgical, Inc.$4K
- Arthrex$2K
- Stryker$99
- Smith+Nephew$87
- Johnson & Johnson$84
- Biocomposites Inc$71
- plus $321 from 11 others
What the payments were for
- Travel & lodging$4146%
- Food & beverage$1,28918%
- Education$5,27076%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Reel Surgical, Inc. | 7 | $3,832 |
| Arthrex | 18 | $2,480 |
| Stryker(2 entities) | 3 | $99 |
| Smith+Nephew | 2 | $87 |
| Johnson & Johnson(2 entities) | 4 | $84 |
| Biocomposites Inc | 1 | $71 |
| Endo Pharmaceuticals Inc. | 3 | $47 |
| Zimmer Biomet | 1 | $46 |
| Amgen | 2 | $44 |
| Vericel Corporation | 2 | $36 |
| Bioventus LLC | 1 | $31 |
| Encore Medical, LP | 1 | $31 |
| Acumed LLC | 1 | $27 |
| Innovation Technologies Inc | 1 | $23 |
| Mimedx Group, Inc. | 1 | $15 |
| Kinex Medical Company LLC | 1 | $13 |
| Fidia Pharma USA Inc. | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SHOULDER IMPLANTS ROTATOR CUFF CUFFMEND$132
How this compares
Too few neuromusculoskeletal medicine, sports medicine providers in Floridato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 127 | $1,362 |
| Meloxicam | 80 | $412 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 49 | $266 |
| Ibuprofen | 26 | $224 |
| Tramadol Hcl | 71 | $185 |
| Methylprednisolone | 22 | $177 |
| Amoxicillin | 18 | $12 |
Paid to pharmacies, not to this prescriber.
Other neuromusculoskeletal medicine, sports medicine in Clermont
- David LucasClermont$4K
- Qahtan AbdulfattahBrooksville$17K
- Raymond WeiandPalm Coast$4K
- Larry FishmanBrandon$521
- Raul CorreaBradenton$517
- Stephen WoodLargo$165
- Scott KazdanPembroke Pines$111
- Michael ZiebelmanWinter Haven$18
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.